ArticleEJNMMI research2025
Global and regional accuracy of deep learning-based tumor segmentation from whole-body [
Article in EJNMMI research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe number of [¹⁸F]fluorodeoxyglucose ([¹⁸F]FDG)-PET/CT scans performed has significantly increased in the last decade in line with the increasing trend of oncological malignancies. Such images, which signal high glucose-uptake areas are key in defining the extent of the disease, staging and response to therapy. Processing and evaluation of ([¹⁸F]FDG)-PET/CT scans, however, require manual annotation by well-trained specialists and above all time. In time and resource-constrained settings meeting the increasing demand for PET/CT scans has become challenging. The main goal of our study was to test the relationship between the volumes predicted by the deep learning algorithm and the manually segmented ones. The secondary objective goal was to measure the extent at which the predictive accuracy is associated with normal background uptake.
resultsThe study sample included 1334 [¹⁸F]FDG-PET/CT scans from subjects with histologically confirmed diagnoses of lung cancer, lymphoma, and melanoma. 933 (70%) [¹⁸F]FDG-PET/CT scans were used as the training dataset and 267 (20%) scans were used as an internal validation dataset. A subsample of 134 (10%) [¹⁸F]FDG-PET/CT scans not used for training was used as the test dataset. The segmentation model was implemented with the nnU-Net convolutional network available in the MONAI framework. Model performance was measured with the Dice score. Correlation between manual and predicted segmentation was assessed using linear correlation. Totalsegmentator tool was used to identify lesions location and assess the tumor-to-background ratio (TBR) for quantitative analysis. Network achieved Dice scores of 0.918 (validation) and 0.879 (test), showing strong agreement with manual segmentations. The model achieved an F1 score of 0.91 on the test set. High correlation (R=0.82, p<0.0001) was observed between predicted and ground truth volumes. Segmentation accuracy improved with higher TBRs, as lesions with TBR>2 had significantly better Dice scores than those with lower contrast (TBR ≤ 1-2 or≤1).
conclusionsThese results are consistent with previous reports on PET-based segmentation, further validating nnU-Net as a reliable approach for detecting hypermetabolic lesions and assessing global disease burden in FDG-PET imaging. Moreover, the significant relationship between TBR and segmentation accuracy suggests the possibility of further improvements by integrating metabolic profile into the predictive model.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.